Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PDD ANAVEX®2-73 (blarcamesine), a voluntary 48-week open-label extension, including microbiome assessment, was initiated and currently 100% of eligible participants have opted into the extension study.
George - In my opinion the 100% extension group also continued taking A2-73 which was part of the study. Thank you
Exactly. 100% of the PDD trial participants have chosen to continue taking A2-73 as well.
Right, Steady T. People that are taking this drug A2-73 are feeling better without side effects. Great sign for a new standard of care in the CNS space. Nothing compares to this drug. Thanks to you.
Right on, Xena. The Standard of care in the CNS space will belong to AVXL. Best to U.
Agree. Placebo is a death sentence. Mandated by drug trial board.
AVXL -Promising drugs A2-73 & 3-71 to the house. Dark to light.
We are Rebel Rebel... Hey baby lets stay out tonight.
Retirees more worried about getting Alzheimer’s than coronavirus: Penny Pennington
https://finance.yahoo.com/video/retirees-more-worried-getting-alzheimer-100000852.html
AVXL 2-73 worth more than gold. Patients going from dark to light. Think if it was you. Put a price tag on it.
Nidan - Xena here they are. Lol, They won't be able to close the window.
https://www.dailymotion.com/video/x2j8ufa
IMO - TGD is fighting some of the worst diseases in CNS known to man. He also has a strong opposition trying to keep promising drugs from reaching the market. David and Goliath. My 1 post today.
JWC3 - Nice post this morning. A move to stealth wealth. Missling smart to move this way.
People can say what they want about Dr. Missling. But I tell you what, he is smarter than the average Bear. GL.
What about Brad Pitt as he was in the movie TROY. Lol. My one post for the day.
Nidan, right. (We will probably never know what the team has been through with this trial (first PM trial, In Spain, proof of concept, more, much more). Wow. This would make a great movie. Can you imagine the exposure of what all goes on behind the scenes? Would show the public what really goes on to get a drug approved. Get past BP big money stronghold.
falconer - George. Autism is huge. AVXL gaining momentum in the CNS space. What will it take to get a competitive market cap to other bios?
Short hyenas keep manipulating this stock down. 255 million MC. Ridiculous.
Ain't no stopping us now.
300 Million MC. Crooked market.
ExtremelyBullishZig - I am putting my car in drive and packing a second gas tank. GLTU
Ladies and gentlemen. Start your engines.
JWC3 - We may hear about it tomorrow. GLTU
What if they were treated on the same fairness level as Biogen.
Nothing is easy.
Great write up Nidan7500 as always. You, falconer, and George should be writers for Anavex. Nice, and thanks for your efforts.
I think so. So is the week after.
Wow- Thank you. We have had a lovely evening. We can be heroes.
I have a pretty good hunch that the stock closes at $5 tomorrow. I would not like to be short going into the weekend. Have a great day.
Maybe a little earlier. Possibly august 2020.
Hi Xena. What is the approximate retail to institutional stock ownership ratio? TIA
Nidan. Right on. I worked with ex-navy guys all my career. Worked large commercial power generation for 35 years.
Nidan7500 - The more people taking 2-73 the faster the word gets out on people feeling better. As we know, a large percentage of the users have good to great response. Better quality of life. A large percentage of trial members continue taking 2-73 post-trial is a huge telltale. Even the shorts will realize that at some point, via $10 -$13 dollar spike up.
I did do a report in my earlier years on US Battleship, you mentioning BB.
Thanks
https://www.navy.mil/navydata/ships/battleships/bb-list.asp
Nidan7500, Your input.(As the transition from treating symptoms to treating causes occur a fundamental change in how /illness/medicine works will simultaneously occur. A science/BIOMED Medical person will be the holder(s) and hopefully AVXL will be the owner of the rights.
Most of us can sense that there is a major transition in how human health care (Biomarker-science are a flag)and related diagnostics/ medical science are about to change bigly. Somewhere in that transition is/are patents which will be worth gazillions. It will be some critical piece of physics or Bio or Chemistry combined w/AI technology (probably yet to be recognized) involving-starting w/ the human CNS initially.)
Great insight, Nidan7500. AVXL cutting edge technology is mind-blowing to the medical community. The cat is out of the bag. GLTU and all AVXL longs.
Georgejjl. Thanks for this information. This patent of treatment is worth $13 to $17 dollars a share IMO. Great job George.
AVXL -Should have a current market cap of 3 to 4 billion dollars IMO. Cutting edge technology in the CNS space.
Turner - Hopefully next week we are in the $20.00's with stellar PDD news and possibly a special guest.
Current market cap at 300M. Real value at 1.5 - 2.5 billion compared to market competition. For the past three years. imo
Great post, Xena. Hey, baby let's stay out tonight.
AVXL - Cutting edge technology in the CNS disease biotech space.
We are REbel Rebel ...
Just a thought. MJFF and Anavex maybe taking A2-73 to market in a joint effort for PDD. Possible. IMO
Also Longtermbeliever may be partnering. He has more shares than some instys. Hold on Loooongs. Lol.